BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 23998716)

  • 1. Polypeptide nanogels with hydrophobic moieties in the cross-linked ionic cores: synthesis, characterization and implications for anticancer drug delivery.
    Kim JO; Oberoi HS; Desale S; Kabanov AV; Bronich TK
    J Drug Target; 2013 Dec; 21(10):981-93. PubMed ID: 23998716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-Step Preparation of pH-Responsive Polymeric Nanogels as Intelligent Drug Delivery Systems for Tumor Therapy.
    Li Y; Bui QN; Duy LTM; Yang HY; Lee DS
    Biomacromolecules; 2018 Jun; 19(6):2062-2070. PubMed ID: 29625005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acid-degradable lactobionic acid-modified soy protein nanogels crosslinked by ortho ester linkage for efficient antitumor in vivo.
    Cheng X; Qin J; Wang X; Zha Q; Yao W; Fu S; Tang R
    Eur J Pharm Biopharm; 2018 Jul; 128():247-258. PubMed ID: 29730261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bio-derived poly(gamma-glutamic acid) nanogels as controlled anticancer drug delivery carriers.
    Bae HH; Cho MY; Hong JH; Poo H; Sung MH; Lim YT
    J Microbiol Biotechnol; 2012 Dec; 22(12):1782-9. PubMed ID: 23221543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted delivery of platinum-taxane combination therapy in ovarian cancer.
    Desale SS; Soni KS; Romanova S; Cohen SM; Bronich TK
    J Control Release; 2015 Dec; 220(Pt B):651-9. PubMed ID: 26381902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly(ethylene glycol) shell-sheddable TAT-modified core cross-linked nano-micelles: TAT-enhanced cellular uptake and lysosomal pH-triggered doxorubicin release.
    Zhang Y; Xiao Y; Huang Y; He Y; Xu Y; Lu W; Yu J
    Colloids Surf B Biointerfaces; 2020 Apr; 188():110772. PubMed ID: 31999965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-reinforced endocytoses of smart polypeptide nanogels for "on-demand" drug delivery.
    Ding J; Xu W; Zhang Y; Sun D; Xiao C; Liu D; Zhu X; Chen X
    J Control Release; 2013 Dec; 172(2):444-55. PubMed ID: 23742879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic breast tumor cell killing achieved by intracellular co-delivery of doxorubicin and disulfiram via core-shell-corona nanoparticles.
    Tao X; Gou J; Zhang Q; Tan X; Ren T; Yao Q; Tian B; Kou L; Zhang L; Tang X
    Biomater Sci; 2018 Jun; 6(7):1869-1881. PubMed ID: 29808221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-targeted, dual reduction- and pH-responsive saccharide/lipoic acid-modified poly(L-lysine) and poly(acrylic acid) polyionic complex nanogels for drug delivery.
    How SC; Chen YF; Hsieh PL; Wang SS; Jan JS
    Colloids Surf B Biointerfaces; 2017 May; 153():244-252. PubMed ID: 28267669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. pH-Responsive chimaeric pepsomes based on asymmetric poly(ethylene glycol)-b-poly(l-leucine)-b-poly(l-glutamic acid) triblock copolymer for efficient loading and active intracellular delivery of doxorubicin hydrochloride.
    Chen P; Qiu M; Deng C; Meng F; Zhang J; Cheng R; Zhong Z
    Biomacromolecules; 2015 Apr; 16(4):1322-30. PubMed ID: 25759951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymer micelles with cross-linked polyanion core for delivery of a cationic drug doxorubicin.
    Kim JO; Kabanov AV; Bronich TK
    J Control Release; 2009 Sep; 138(3):197-204. PubMed ID: 19386272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A New Strategy for Intestinal Drug Delivery via pH-Responsive and Membrane-Active Nanogels.
    Wang S; Ha Y; Huang X; Chin B; Sim W; Chen R
    ACS Appl Mater Interfaces; 2018 Oct; 10(43):36622-36627. PubMed ID: 30300550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Charge-conversional and reduction-sensitive poly(vinyl alcohol) nanogels for enhanced cell uptake and efficient intracellular doxorubicin release.
    Chen W; Achazi K; Schade B; Haag R
    J Control Release; 2015 May; 205():15-24. PubMed ID: 25445693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folate-decorated nanogels for targeted therapy of ovarian cancer.
    Nukolova NV; Oberoi HS; Cohen SM; Kabanov AV; Bronich TK
    Biomaterials; 2011 Aug; 32(23):5417-26. PubMed ID: 21536326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redox-responsive degradable prodrug nanogels for intracellular drug delivery by crosslinking of amine-functionalized poly(N-vinylpyrrolidone) copolymers.
    Peng H; Huang X; Melle A; Karperien M; Pich A
    J Colloid Interface Sci; 2019 Mar; 540():612-622. PubMed ID: 30690386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bile Acid-Based Drug Delivery Systems for Enhanced Doxorubicin Encapsulation: Comparing Hydrophobic and Ionic Interactions in Drug Loading and Release.
    Cunningham AJ; Robinson M; Banquy X; Leblond J; Zhu XX
    Mol Pharm; 2018 Mar; 15(3):1266-1276. PubMed ID: 29378128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted Smart pH and Thermoresponsive N,O-Carboxymethyl Chitosan Conjugated Nanogels for Enhanced Therapeutic Efficacy of Doxorubicin in MCF-7 Breast Cancer Cells.
    Verma NK; Purohit MP; Equbal D; Dhiman N; Singh A; Kar AK; Shankar J; Tehlan S; Patnaik S
    Bioconjug Chem; 2016 Nov; 27(11):2605-2619. PubMed ID: 27643823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanomicelles based on a boronate ester-linked diblock copolymer as the carrier of doxorubicin with enhanced cellular uptake.
    Xu Y; Lu Y; Wang L; Lu W; Huang J; Muir B; Yu J
    Colloids Surf B Biointerfaces; 2016 May; 141():318-326. PubMed ID: 26874117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A co-delivery system based on paclitaxel grafted mPEG-b-PLG loaded with doxorubicin: preparation, in vitro and in vivo evaluation.
    Li Q; Lv S; Tang Z; Liu M; Zhang D; Yang Y; Chen X
    Int J Pharm; 2014 Aug; 471(1-2):412-20. PubMed ID: 24905776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pH-sensitive polymeric nanoparticles of mPEG-PLGA-PGlu with hybrid core for simultaneous encapsulation of curcumin and doxorubicin to kill the heterogeneous tumour cells in breast cancer.
    Yuan JD; ZhuGe DL; Tong MQ; Lin MT; Xu XF; Tang X; Zhao YZ; Xu HL
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):302-313. PubMed ID: 29301415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.